Acurx Pharmaceuticals (ACXP) Misses Q4 EPS by 12c
Get Alerts ACXP Hot Sheet
Join SI Premium – FREE
Acurx Pharmaceuticals (NASDAQ: ACXP) reported Q4 EPS of ($0.37), $0.12 worse than the analyst estimate of ($0.25).
For earnings history and earnings-related data on Acurx Pharmaceuticals (ACXP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Okta upgraded as AI security opportunity boosts outlook
- SunEdison (SUNE) Misses Q2 EPS by 52c
- Kamada Ltd. (KMDA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share